Locations:
SearchAdvertisement
Oral medication reduces epistaxis and improves quality of life for patients with rare vascular disorder
The disorder can greatly impact patients’ quality of life, but sclerotherapy and a multidisciplinary approach to care can be life-changing
A comparison with cautery/laser
Study points to efficacy of two modalities of bevacizumab
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement